Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Huntington's Disease Treatment Market Size, Share & Trends Analysis Report, 2018-2023 - ResearchAndMarkets.com

Research and Markets
Posted on: 09 Nov 18

The "Huntington's Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Symptomatic Therapy, Disease-modifying Therapy), By Major Markets, And Segment Forecasts, 2018 - 2023" report has been added to ResearchAndMarkets.com's offering.

The global Huntington's disease treatment market size is expected to be valued at USD 1.5 billion by 2023, registering a CAGR of 38.2% during the forecast period.

The market is largely driven by factors such as rapid uptake of disease-modifying therapies, increased adoption of novel therapeutics, and increase in R&D activities.

Huntington's disease is an inherited neurodegenerative disorder characterized by a combination of motor, cognitive, and psychiatric symptoms. Currently, only two symptom-alleviating therapies are specifically approved for this disorder: Xenazine and Austedo. Off-label medications are used extensively due to lack of approved alternatives.

The pipeline for Huntington's disease is expected to witness rapid developments in the coming years as disease-modifying drugs transform the market landscape. Improved disease understanding has led to significant progress in the development of therapeutic approaches aimed at modifying specific changes linked to the causative mutation.

The potential role of RNA antisense technology and stem cell therapy are under active clinical investigation. Wave Life Sciences and Ionis Pharma's antisense oligonucleotides aim to target underlying disease cause and are expected to contribute significantly to market growth.

Key Topics Covered:

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Disease Primer and Epidemiology

Chapter 4 Global Huntington's Disease Treatment Market Overview

Chapter 5 Huntington's Disease Treatment Market: Pipeline Intelligence

Chapter 6 Company Profiles

  • Valeant Pharmaceuticals
  • Teva Pharmaceuticals
  • Ionis Pharmaceuticals
  • Wave Life Sciences
  • Horizon Pharma
  • Prana Biotech

For more information about this report visit https://www.researchandmarkets.com/research/gd4t49/global?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181109005253/en/

Business Wire
www.businesswire.com

Last updated on: 09/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.